Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 37,000 ZBIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Zenas BioPharma, Inc. (ZBIO) | Grant/Award | 37,000 | n/a |
| Jul 29, 2026 | Bicara Therapeutics Inc. (BCAX) | Grant/Award | 38,950 | n/a |
| Jul 15, 2026 | Nuvalent, Inc. (NUVL) | Tender of Shares | 1,324 | $164.2K |
| Jun 18, 2026 | Nuvalent, Inc. (NUVL) | Grant/Award | 3,444 | n/a |
| May 26, 2026 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 17,084 | n/a |
| May 26, 2026 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 15,508 | n/a |
| Apr 8, 2026 | Replimune Group, Inc. (REPL) | Grant/Award | 44,500 | n/a |
| Jun 20, 2025 | Nuvalent, Inc. (NUVL) | Grant/Award | 3,971 | n/a |
| May 29, 2025 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 4,600 | n/a |
| May 16, 2025 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 14,000 | n/a |